Ann Cunningham, MBA, has more than 20 years of pharma/biotech experience, including senior executive positions. She most recently served as Chief Commercial Officer at Vistagen Therapeutics, where she also serves on the Board of Directors.
Her career began as a social worker in a county jail where her passion for serving underserved and overlooked communities was ignited. After witnessing decades of inequity, she decided to leverage her pharma expertise, lived experience, and entrepreneurial spirit to establish i3 Strategy Partners. Ann’s firm works with pharma companies to enable full participation in the healthcare system, including clinical trial participation. She and her team have initiated Wellness WoRx, a high-touch community outreach initiative whose mission is to improve the overall health and wellness of underserved individuals, families, and communities to ultimately create health equity for all.
She holds a BA in Psychology from Yale University and an MBA from the University of Michigan.
Main Menu
The Learning Phase includes:
Connecting Clinical Trial Sponsors: Bringing sponsors and local EQBMED-selected sites together to work as partners.
Sharing Key Learnings: Sharing important lessons learned from these partnerships.
Building Robust Infrastructure: Creating a strong support system that continues to support the growth and aspirations of local sites.